Kohmann Bosshard Financial Services LLC Purchases New Stake in Teleflex Incorporated (NYSE:TFX)

Kohmann Bosshard Financial Services LLC purchased a new position in Teleflex Incorporated (NYSE:TFX) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 409 shares of the medical technology company’s stock, valued at approximately $73,000.

A number of other hedge funds have also recently modified their holdings of TFX. Avior Wealth Management LLC boosted its holdings in shares of Teleflex by 190.6% during the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 101 shares during the period. Ashton Thomas Securities LLC purchased a new stake in Teleflex in the 3rd quarter worth approximately $40,000. True Wealth Design LLC lifted its stake in Teleflex by 16,600.0% in the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after acquiring an additional 166 shares during the period. Capital Performance Advisors LLP bought a new stake in shares of Teleflex during the 3rd quarter valued at about $54,000. Finally, Banque Cantonale Vaudoise boosted its position in Teleflex by 184.8% during the 3rd quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock valued at $56,000 after acquiring an additional 146 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

TFX has been the subject of a number of research analyst reports. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research note on Friday. Wells Fargo & Company dropped their target price on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a report on Friday. Truist Financial reduced their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Royal Bank of Canada cut shares of Teleflex from an “outperform” rating to a “sector perform” rating and lowered their price target for the company from $220.00 to $155.00 in a research report on Friday. Finally, Citizens Jmp cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday. Nine research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $196.83.

Teleflex Price Performance

Shares of NYSE:TFX opened at $132.58 on Monday. Teleflex Incorporated has a 1-year low of $130.60 and a 1-year high of $249.90. The business has a fifty day moving average price of $175.44 and a 200-day moving average price of $204.65. The company has a market capitalization of $6.16 billion, a PE ratio of 26.36, a PEG ratio of 1.73 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be given a $0.34 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.03%. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.